Adaptive Biotechnologies Corporation Profile Avatar - Palmy Investing

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer …

Biotechnology
US, Seattle [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Adaptive Biotechnologies Corporation mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ADPT's Analysis
CIK: 1478320 CUSIP: 00650F109 ISIN: US00650F1093 LEI: - UEI: -
Secondary Listings
ADPT has no secondary listings inside our databases.